180 Life Sciences Corp. Common Stock
ATNF
Open
$1.01
Open
$0.03(2.68%)
Today
About
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company is headquartered in Palo Alto, California. The company went IPO on 2017-06-07. The firm is focused on iGaming sector, through its iGaming Technology Platform. The firm also continues to evaluate monetization strategies for its biotechnology assets.
Key stats
Open
$1.14
Volume
7.50K
Market cap
$5.64M
Prev. close
$0.99
Impl / hst vl
-
Open interest
$0.00
$0.00
Day’s Range
$0.00
$0.66
52W Range
$17.75
Valuation
27
Valuation score
Overvalued
P/E
-
P/S
-
P/B
0.49
Current ratio
1.02
Debt / Equity
-0.46
ROE
-108.44%
Gross margin
-
Income growth
-80.71%
FCF growth
-10.20
Analysts estimates
Consensus rating
Buy
The average rating from top 7 analysts indicates that stock is expected to perform in line with the market
Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$81.60
The top 3 analysts forecasts that 12-month price may increase by 7,979.21%, with a low of $80.80 and a high of $84.00
$80.80
Low
$81.60
Avg
$84.00
High
Current price
Earnings
Q1 ‘25 revenue
$0.00
Q1 ‘25 net income
-$2.37M
Revenue
Net income
Previous EPS
-Estimate EPS
$0.00
Actual EPS
Estimate EPS